Tuala, Shella Rose .
HRN: 24-21-00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/13/2024
CEFUROXIME 1.5GM (VIAL)
01/13/2024
01/14/2024
IV
1.5
Q8
LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes